FDA Coronavirus (COVID-19) Update: April 24th, 2020
April 24, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) has announced the following actions taken in its ongoing response effort to the COVID-19 Coronavirus pandemic:
Thursday, the FDA issued a guidance on non-invasive fetal and maternal monitoring devices to help increase the availability and capability of these devices used to support patient monitoring during the COVID-19 Coronavirus pandemic.
Coronavirus
American Stroke Association says Advanced MRI Brain Scan may help predict Stroke-Related Dementia
October 13, 2019
Dallas, TX – An advanced Magnetic Resonance Imaging (MRI) brain scan analysis in patients with stroke-related, small vessel disease helped predict problems with thinking, memory and even dementia, according to new research published in Stroke, a journal of the American Stroke Association, a division of the American Heart Association.
An advanced MRI brain scan analysis in patients with stroke-damaged blood vessels helped predict problems with thinking (planning, organizing information and processing speed) and dementia. (American Heart Association)
Hypertension Drug may hold promise for Alzheimer’s Disease
July 10, 2019
Dallas, TX – According to new research in the American Heart Association’s journal Hypertension, while seeking new treatments to slow the progression of Alzheimer’s disease, researchers found the blood pressure drug nilvadipine increased blood flow to the brain’s memory and learning center among people with Alzheimer’s disease without affecting other parts of the brain.
These findings indicate that the known decrease in cerebral blood flow in patients with Alzheimer’s can be reversed in some regions. However, it is unclear if this translates to clinical benefits. (American Heart Association)
